News

Deal Announcements

Asthmatx Secures $50 Million Strategic Investment

Wednesday, May 16, 2007 5:00:00 AM PDT | VentureDeal Staff
MOUNTAIN VIEW, CA -- Medical device developer Asthmatx announced that it has received a $50 million equity investment in return for a 15% stake in the company.  The stake values the company at an effective $335 million post-money.

Asthmatx is developing catheter-based medical devices for the treatment of severa asthma via its Alair(R) System, which the company claims to have demonstrated a reduction of the narrowing of airway passages.

The investor was Olympus Medical Systems Corp. of Tokyo, Japan.  The company said the proceeds would fund its operations through FDA approval and market launch of its device.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1